logo

CNTX

Context Therapeutics·NASDAQ
--
--(--)
--
--(--)

CNTX fundamentals

Context Therapeutics (CNTX) released its earnings on Aug 6, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.09 (YoY -125.00%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.09
-125.00%
Report date
Aug 6, 2025
EPS
Q3,undefined
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-0.58-0.22-0.25-0.24-0.22-0.4-0.31-0.37-0.42-0.23-0.04-0.22-0.03-0.05-0.09
Forecast
-0.27-0.24-0.25-0.25-0.295-0.19-0.195-0.31-0.3633-0.44-0.0667-0.09-0.092-0.058-0.0615
Surprise
0.00%
-114.81%
+8.33%
0.00%
+4.00%
+25.42%
-110.53%
-58.97%
-19.35%
-15.61%
+47.73%
+40.03%
-144.44%
+67.39%
+13.79%
-46.34%
Revenue
Q3,undefined
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
--000000000000000
Forecast
--000000000000000
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Earnings Call